Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781817 · ClinicalTrials.gov registry record · Phase 4
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT03781817 is a Phase 4 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants.
The verdict
NCT03781817, a Phase 4 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This a randomized clinical trial involving children with non-operative fractures presenting the emergency department randomized either to intranasal or intravenous ketamine.
Interventions
- DRUG Intranasal Ketamine
- DRUG Intravenous Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2022-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03781817
The ClinicalTrials.gov registry entry for NCT03781817 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intranasal Ketamine is the first listed.
NCT03781817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03781817 about?
NCT03781817 is a clinical study titled "Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures". This a randomized clinical trial involving children with non-operative fractures presenting the emergency department randomized either to intranasal or intravenous ketamine.
What is the current status of trial NCT03781817?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-09-09. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT03781817?
The interventions under investigation include: Intranasal Ketamine (DRUG), Intravenous Ketamine (DRUG).
Who is sponsoring clinical trial NCT03781817?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.